Skip to main content
. Author manuscript; available in PMC: 2022 Jul 29.
Published in final edited form as: Eur Respir J. 2019 May 18;53(5):1900102. doi: 10.1183/13993003.00102-2019

Table 2.

Top differentially expressed genes from the meta-analysis of atopy

EVA-PR
BAMSE
Meta-analysis
Gene Symbol Description Fold Change P Value FDR Fold Change P Value FDR* Fold Change P Value FDR

SIGLEC8 Sialic acid binding Ig like lectin 8 1.18 2.97×10−12 2.51×10−08 1.05 9.34×10−03 NS 1.10 8.07×10−13 2.86×10−08
IL5RA Interleukin 5 receptor subunit alpha 1.15 2.06×10−09 3.48×10−06 1.18 1.97×10−04 NS 1.16 2.03×10−12 3.59×10−08
IL17RB Interleukin 17 receptor B 1.19 1.29×10−14 2.18×10−10 1.01 2.39×10−01 NS 1.04 5.14×10−12 6.07×10−08
SLC29A1 Solute carrier family 29 member 1 (Augustine blood group) 1.15 1.23×10−09 2.31×10−06 1.05 9.24×10−04 NS 1.07 7.07×10−12 6.26×10−08
SMPD3 Sphingomyelin phosphodiesterase 3 1.15 2.44×10−10 1.03×10−06 1.04 5.31×10−03 NS 1.07 1.48×10−11 1.05×10−07
IL1RL1 Interleukin 1 receptor like 1 1.14 6.15×10−09 8.94×10−06 1.13 2.24×10−03 NS 1.14 8.46×10−11 4.99×10−07
ALOX15 Arachidonate 15-lipoxygenase 1.15 9.79×10−10 2.11×10−06 1.11 1.22×10−02 NS 1.14 1.48×10−10 7.50×10−07
OLIG2 Oligodendrocyte transcription factor 2 1.17 5.22×10−12 2.×10 −08 1.01 3.18×10−01 NS 1.06 7.96×10−10 3.52×10−06
PIK3R6 Phosphoinositide-3-kinase regulatory subunit 6 1.12 9.07×10−08 7.×10 −05 1.05 2.41×10−03 NS 1.07 1.04×10−09 4.10×10−06
CLC Charcot-Leyden crystal galectin 1.14 2.54×10−08 2.×10 −05 1.17 9.22×10−03 NS 1.14 1.65×10−09 5.85×10−06
ADORA3 Adenosine A3 receptor 1.14 6.58×10−09 8.94×10−06 1.04 2.47×10−02 NS 1.07 1.95×10−09 6.27×10−06
CEBPE CCAAT/enhancer binding protein epsilon 1.12 1.04×10−06 6.04×10−04 1.07 2.32×10−03 NS 1.09 9.52×10−09 2.59×10−05
PMP22 Peripheral myelin protein 22 1.15 1.00×10−09 2.11×10−06 1.02 1.75×10−01 NS 1.06 1.05×10−08 2.66×10−05
PRSS33 Protease, serine 33 1.15 7.21×10−10 2.03×10−06 1.01 3.15×10−01 NS 1.05 2.77×10−08 6.55×10−05
PTGDR2 Prostaglandin D2 receptor 2 1.12 3.85×10−07 2.60×10−04 1.04 2.34×10−02 NS 1.07 5.61×10−08 1.17×10−04
RAB44 Member RAS oncogene family 1.08 6.77×10−05 2.11×10−02 1.07 2.39×10−04 NS 1.07 7.15×10−08 1.41×10−04
HRASLS5 HRAS like suppressor family member 5 1.14 2.11×10−08 2.19×10−05 1.02 1.60×10−01 NS 1.05 9.10×10−08 1.69×10−04
HRH4 Histamine receptor H4 1.11 4.78×10−06 2.18×10−03 1.10 7.45×10−03 NS 1.11 1.37×10−07 2.42×10−04
CCR3 C-C Motif Chemokine Receptor 3 1.11 1.20×10−05 4.72×10−03 1.15 4.20×10−03 NS 1.11 1.77×10−07 2.85×10−04
CDK15 Cyclin dependent kinase 15 1.14 8.22×10−09 9.25×10−06 1.01 3.56×10−01 NS 1.03 2.14×10−07 3.29×10−04

All models were adjusted for age, sex, asthma status, batch, and proportions of white blood cell subtypes (eosinophils, lymphocytes, neutrophils and monocytes). Models in EVA-PR were additionally adjusted for principal components.

*

NS means non-significant, i.e., FDR-adjusted P value > 0.05.